Spectral Medical Inc. (OTCMKTS:EDTXF – Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 30th, there was short interest totalling 100,000 shares, a growth of 7.9% from the September 15th total of 92,700 shares. Based on an average daily volume of 35,900 shares, the days-to-cover ratio is currently 2.8 days.
Spectral Medical Stock Performance
Shares of Spectral Medical stock opened at $0.42 on Friday. The company has a market capitalization of $116.92 million, a PE ratio of -8.34 and a beta of 0.93. The company has a 50-day simple moving average of $0.47 and a two-hundred day simple moving average of $0.40. Spectral Medical has a one year low of $0.22 and a one year high of $0.55.
Spectral Medical (OTCMKTS:EDTXF – Get Free Report) last posted its quarterly earnings data on Friday, August 9th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.34 million for the quarter.
About Spectral Medical
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Featured Articles
- Five stocks we like better than Spectral Medical
- 5 Top Rated Dividend Stocks to Consider
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- What is the Nikkei 225 index?
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- What Does a Stock Split Mean?
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.